This report provides key findings from the 2022 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment among the noninstitutionalized U.S. population aged 12 or older. Estimates are presented by age group and by race/ethnicity for selected measures.
Dashboard: Filter Bricks
Main page content
![Results from the 2022 National Survey on Drug Use and Health (NSDUH): Key Substance Use and Mental Health Indicators in the United States](/sites/default/files/styles/product_thumbnail_dashboard/public/pep23-07-01-006.png?itok=ulWQrMTX)
![Results from the 2021 National Survey on Drug Use and Health (NSDUH): Key Substance Use and Mental Health Indicators in the United States](/sites/default/files/styles/product_thumbnail_dashboard/public/pep22-07-01-005.png?itok=5VO0XuMd)
Read key findings from the 2021 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. Estimates are presented by age group and by race/ethnicity for selected measures. Unlike other NSDUH Annual National Reports, the 2021 report has no discussion of trends over time, because changes in survey methodology mean the indicators are not comparable to past NSDUH estimates.
![Racial/Ethnic Differences in Mental Health Service Use among Adults and Adolescents](/sites/default/files/styles/product_thumbnail_dashboard/public/pep21-07-01-002.png?itok=zM1RM7DZ)
This chartbook uses combined 2015 to 2019 data from the National Survey on Drug Use and Health (NSDUH) to present nationally representative estimates of mental health service utilization among adults aged 18 or older and adolescents aged 12 to 17 within different racial/ethnic groups in the United States. The percentages are annual averages.
![Employee Assistance Program (EAP) Prescription Drug Toolkit and Fact Sheets](/sites/default/files/styles/product_thumbnail_dashboard/public/pep20-03-02-001.png?itok=sZXatWdB)
The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).
![Advisory: Using Motivational Interviewing in Substance Use Disorder Treatment (based on TIP 35)](/sites/default/files/styles/product_thumbnail_dashboard/public/PEP20-02-02-014.jpg?itok=PN1Iz648)
This Advisory is based on TIP 35, Enhancing Motivation for Change in Substance Use Disorder Treatment. It addresses the spirit, application, and fundamentals of motivational interviewing (MI), discusses how practitioners can effectively employ MI in substance use disorder (SUD) treatment, and provides tools that practitioners can use to encourage and promote lasting positive outcomes for their clients.
![Advisory: The Substance Use Disorder Counseling Competency Framework: An Overview (based on TAP 21)](/sites/default/files/styles/product_thumbnail_dashboard/public/PEP20-02-01-017.jpg?itok=WruhsXj4)
This Advisory is based on Technical Assistance Publication (TAP) 21, Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice. It discusses the development of the counseling competencies and the validated research on which they are based, provides a simplified overview of their structure and the elements of a typical competency, and outlines how these competencies are changing the field of substance use disorder (SUD) treatment nationwide. The Advisory also addresses the critical role of cultural competency.
![Treating Babies Who Were Exposed to Opioids Before Birth](/sites/default/files/styles/product_thumbnail_dashboard/public/sma18-5071fs3.jpg?itok=X-ePDrIx)
This fact sheet (3 of 4) talks about what pregnant women with opioid use disorder should know about and expect after the birth of their baby. This resource includes information about neonatal abstinence syndrome, baby’s needs after birth, and do’s and don’ts for understanding and responding to baby’s needs.
![Healthy Pregnancy Healthy Baby Fact Sheets](/sites/default/files/styles/product_thumbnail_dashboard/public/sma18-5071.jpg?itok=XUo9-BkG)
This series of four fact sheets emphasizes the importance of continuing a mother's treatment for opioid use disorder (OUD) throughout pregnancy. The series includes information on OUD and pregnancy, OUD treatment, neonatal abstinence syndrome, and considerations to address before hospital discharge.
![](/sites/default/files/styles/product_thumbnail_dashboard/public/sma18-5069qg.jpg?itok=2fERj8cY)
This quick guide contains an overview of the challenges associated with tobacco cessation and the benefits of being tobacco-free for individuals as well as those of a smoke-free workplace. It also includes tips that substance use disorder treatment settings can use to implement their own tobacco cessation programs.
![Good Care for You and Your Baby While Receiving Opioid Use Disorder Treatment](/sites/default/files/styles/product_thumbnail_dashboard/public/sma18-5071fs4.jpg?itok=8j6laSWF)
This fact sheet (4 of 4) addresses the care of women with opioid use disorder (OUD) and care of their babies after pregnancy. This resource includes information on managing OUD, caring for baby, and do’s and don’ts for creating a healthy environment at home.
Displaying 1 - 10 out of 49